Please login to the form below


Post-COVID-19 thinking: outputs from a thought leader forum

On 14 May 2020, a group of industry experts across pharma and biotech Zoomed together to share reflections on the impact of COVID-19 so far and the implications for how we should evolve in the coming months and years:
Download full article here


Biggest impact of COVID-19

  • COVID-19 has had a significant impact on how the industry works; maintaining individuals’ well-being and finding the best ways to integrate digital has challenged many companies
  • Clinical trials have been affected, in particular, recruitment and progress. It was also noted that certain metrics and data collection are likely to be affected and may have an impact on future regulatory submissions
  • Our forum concluded that in general we expect sales of established medicines to be above expectations, with newer therapies likely to be behind budget, due mainly to patients not attending clinic and a reduced new/switched/repeat dynamic

Biggest concerns

  • We highlighted concern that future pricing may be affected. Government debt has been affected by COVID-19 and this may impact future pricing negotiations and also see a quicker transition to outcomes-based pricing
  • Our recommendation is that the industry needs to continue to build trust. Vaccine and COVID-19 treatment costs will be high-profile negotiations and may affect reputation or profits.
  • There is an opportunity for the industry to transition its reputation from medicines developers to healthcare providers
  • The industry needs to evolve how it works digitally, but we don’t expect a revolution, rather a gradual upskilling of organisations and of its people to enable more effective working. How this is done, however, is still uncertain, and is an opportunity for better collaboration

Biggest opportunities

  • We concluded that re-shaping how the field force evolve and work is a huge opportunity for the industry to add more value to society. How to add value through a truly multi-channel approach is an exciting opportunity for our industry, and a key opportunity for future discussion
  • The industry has spent millions on congress attendance for so many years. How the industry has recently operated offers an opportunity to re-think how to engage with congresses, but more importantly how to engage with healthcare professionals throughout the year. We don’t see a time when congresses are not important, but whether medical communications are anchored to congresses in the future is an opportunity to explore
  • It’s difficult to predict the new normal, but we know digital and user experience will be critical to effective commercialisation. This provides an exciting opportunity for our industry to create compelling digital experiences for brand and organisations to communicate with their audiences
  • We expect increased pricing pressure in the future. The organisations that adapt best, by providing real-world evidence, outcomes-based evidence and pricing, and support service re-design, will lead the future industry

Download full article here

23rd June 2020



Company Details

Lucid Group Communications Limited

0345 0536671

Contact Website

First Floor, Jubilee House
Third Avenue
Globe Park

Latest content on this profile

Lucid Group Welcomes a New Cohort of Graduates into its Futures Academy

Lucid Group Communications Limited
We let your whole self shine
People are at the heart of who we are. Our aim is to transform the lives of those we touch without prejudice or discrimination. At Lucid, the magic we create relies on harnessing the unique, diverse and individual talents of those we work with. To do this we must empower each person to bring their whole self to work so we can be fully inclusive and collaborate with a full heart – fulfilling the potential of everything we do and everyone we work with. Equally.If you're looking for a purpose-driven healthcare communications consultancy with a mission to transform the lives of those it touches, including patients, clients, our teams and our community, then please get in touch.Our industry-leading learning and development programmes are designed to support your ambitions and professional growth.So come and join our gang; let's be the change together and help transform lives.You can check out our open roles here contact one of our talent acquisition managers for a chat:Elaine DowneyDaniel NewburyJon TurnerEllen Field Assoc CIPD
Lucid Group Communications Limited
Climbing my own Lucid Ladder

Lucid Group Communications Limited
A Lucid Thirsty Thursday D&I Special

Lucid Group Communications Limited
Connecting capabilities in healthcare communications

Lucid Group Communications Limited
Connecting capabilities in healthcare communications
The account management/medical writing paradigm was the cornerstone of medcomms for many years, but evolution in technology, storytelling and an increasingly sophisticated audience has changed this.Instead, today's environment requires an integrated, multi-disciplinary approach to cut through the noise, change behaviour, build mental availability for a brand, and advance health outcomes.Connecting multiple capabilities has never been so important. So, how are agencies managing this today?In this webinar, we discuss how our client teams have evolved and how traditional roles have had to change and adapt to help solve today's healthcare challenges.The Lucid Group panel are Jonathan Andrew, Hannah Clarke, Cheryl Harrison Doyle and Madeleine Tye. Please reach out to them on LinkedIn should you have any questions relating to this. As you will hear in this webinar, we are constantly evolving and growing our team's capabilities; both through talent acquisition and internal training opportunities. So, if you're looking for a new career move with a company that offers industry-leading learning development opportunities and growth within your role, please check out all our open roles here:
Lucid Group Communications Limited